PATENT CLAIM ANALYSIS

Application Number: 16110607
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "623000"]

Abstract:
Methods for treating or preventing one or more symptoms of rheumatoid arthritis or other types of inflammatory arthritis involves administering a formulation containing an effective amount of arsenic trioxide to an affected patient. The arsenic trioxide formulation can be administered orally, for example, as a solution, suspension, syrup, emulsion, tablet, or capsule.

Claim (Index 12):
The pharmaceutical formulation of  claim 10 , wherein the arsenic trioxide is in a pharmaceutically acceptable carrier for local administration to a synovial joint.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 96.0
- Lexical Diversity: 1.45238
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12781970', '14937439', '15027375', '11880121', '10697599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7194608071224156
- 35 USC 102 Novelty (BERT): 0.5850627726883334
- Combined Prediction Score: 0.7060210036790073
- Mean Citation Score: 297.77935
- Max Citation Score: 604.05536
- Similarity Product: 374.8494920188713

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test